GlassScriptPhysician profile
Chakravarthy Raghavan
NPI 1396848354
$12,792.19
in general payments reported to CMS, 2019-2025
25 companies · $1,544 in 2025
The $1,544 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,783 · 2020: $291 · 2021: $2,539 · 2022: $710 · 2023: $744 · 2024: $3,181 · 2025: $1,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,135 · Travel and Lodging: $1,264 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,135.40 |
| Travel and Lodging | $1,263.72 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $6,911.12 | 2019-2025 | Amvia Edge, Pamira, Selectra |
| Abbott Laboratories | $1,486.45 | 2019-2024 | Gallant, Allure Quadra, Jot Dx |
| Kestra Medical Technology Services, INC. | $1,293.72 | 2023-2025 | Assure Wcd |
| Medtronic, INC. | $524.84 | 2021-2025 | Corevalve Evolut R, Selectsecure, Azure Xt Dr Mri Surescan |
| Abiomed | $519.05 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $418.52 | 2022-2024 | Optimizer |
| Shockwave Medical, INC | $313.50 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $178.44 | 2024-2025 | Wainua, Farxiga |
| Esperion Therapeutics, INC. | $177.37 | 2023-2024 | Nexletol |
| Pfizer INC. | $155.89 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $134.11 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $114.53 | 2025 | Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $101.52 | 2019-2025 | |
| Becton, Dickinson and Company | $70.00 | 2024-2025 | Bd Introsyte, Introducer Needle |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.22 | 2019-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $59.37 | 2019 | |
| Sanofi-Aventis U.S. LLC | $50.57 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $42.52 | 2019-2022 | |
| Biosense Webster, INC. | $39.63 | 2024 | Nuvision Ice Catheter |
| Elutia, INC. | $35.18 | 2024 | Ecm Patch,Pouch |
| Atricure, INC. | $25.57 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Ge Healthcare | $25.18 | 2025 | |
| Cvrx, INC. | $19.12 | 2024 | Barostim Neo System |
| Philips North America LLC | $15.77 | 2023 | |
| Amgen INC. | $15.00 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chakravarthy Raghavan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.